These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 15592731)
1. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Zeitlhofer J; Saletu B J Neurol; 2004 Nov; 251(11):1354-63. PubMed ID: 15592731 [TBL] [Abstract][Full Text] [Related]
2. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594 [TBL] [Abstract][Full Text] [Related]
3. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965 [TBL] [Abstract][Full Text] [Related]
4. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography). Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151 [TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575 [TBL] [Abstract][Full Text] [Related]
7. Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA). Saletu B; Anderer P; Saletu-Zyhlarz GM; Gruber D; Metka M; Huber J Psychopharmacology (Berl); 2005 Apr; 178(4):389-99. PubMed ID: 15765254 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292 [TBL] [Abstract][Full Text] [Related]
9. Effects of modafinil on symptomatology of human narcolepsy. Boivin DB; Montplaisir J; Petit D; Lambert C; Lubin S Clin Neuropharmacol; 1993 Feb; 16(1):46-53. PubMed ID: 8093681 [TBL] [Abstract][Full Text] [Related]
10. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC; Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292 [TBL] [Abstract][Full Text] [Related]
11. Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil. Ellis CM; Monk C; Simmons A; Lemmens G; Williams SC; Brammer M; Bullmore E; Parkes JD J Sleep Res; 1999 Jun; 8(2):85-93. PubMed ID: 10389090 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of modafinil in 10 Taiwanese patients with narcolepsy: findings using the Multiple Sleep Latency Test and Epworth Sleepiness Scale. Yeh SB; Schenck CH Kaohsiung J Med Sci; 2010 Aug; 26(8):422-7. PubMed ID: 20705253 [TBL] [Abstract][Full Text] [Related]
13. Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test. van der Heide A; van Schie MK; Lammers GJ; Dauvilliers Y; Arnulf I; Mayer G; Bassetti CL; Ding CL; Lehert P; van Dijk JG Sleep; 2015 Jul; 38(7):1051-8. PubMed ID: 25902810 [TBL] [Abstract][Full Text] [Related]
14. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression. Saletu B; Anderer P; Saletu-Zyhlarz GM Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572 [TBL] [Abstract][Full Text] [Related]
15. Modafinil for narcolepsy: systematic review and meta-analysis. Golicki D; Bala MM; Niewada M; Wierzbicka A Med Sci Monit; 2010 Aug; 16(8):RA177-86. PubMed ID: 20671626 [TBL] [Abstract][Full Text] [Related]
16. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study. Joo EY; Tae WS; Jung KY; Hong SB J Sleep Res; 2008 Mar; 17(1):82-8. PubMed ID: 18275558 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772 [TBL] [Abstract][Full Text] [Related]
18. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Black J; Pardi D; Hornfeldt CS; Inhaber N Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998 [TBL] [Abstract][Full Text] [Related]
19. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
20. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial. Philip P; Chaufton C; Taillard J; Capelli A; Coste O; Léger D; Moore N; Sagaspe P Sleep; 2014 Mar; 37(3):483-7. PubMed ID: 24587570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]